NMRA vs VRTX · $283.5M cap vs P/E 30, rev $12.00B
Neumora Therapeutics, Inc. (NMRA) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
NMRA does not have a complete income-statement cache yet.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
NMRA currently screens at market cap $283.5M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the NMRA and VRTX stock pages for the full models.
Not investment advice.